- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.76 Å
- Oligo State
- hetero-1-1-1-1-mer
- Ligands
- 1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 1 x FWZ: (2~{S},4~{R})-~{N}-[[2-[2-[4-[[4-[3-azanyl-6-(2-hydroxyphenyl)pyridazin-4-yl]piperazin-1-yl]methyl]phenyl]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-1-[(2~{S})-2-[(1-fluoranylcyclopropyl)carbonylamino]-3,3-dimethyl-butanoyl]-4-oxidanyl-pyrrolidine-2-carboxamide(Non-covalent)
- 2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Farnaby, W. et al., BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design. Nat.Chem.Biol. (2019)
- Release Date
- 2019-06-12
- Peptides
- Transcription activator BRG1: A
von Hippel-Lindau disease tumor suppressor: B
Elongin-C: C
Elongin-B: D - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H